| This article has been cited by |
| 1 | Alopecia Areata: a Comprehensive Review of Pathogenesis and Management | |
| Ralph M. Trüeb,Maria Fernanda Reis Gavazzoni Dias |
| Clinical Reviews in Allergy & Immunology.2018;54(1)68 |
| [DOI] |
|
| 2 | Treatments for alopecia areata: A systematic review and network meta-analysis | |
| Takeshi Fukumoto,Rie Fukumoto,Elizabeth Magno,Masahiro Oka,Chikako Nishigori,Nobuyuki Horita |
| Dermatologic Therapy.2021;34(3)68 |
| [DOI] |
|
| 3 | Topical diphenylcyclopropenone in the treatment of alopecia areata: A 10-year follow-up of 86 cases in a single center | |
| Chang-Ming Huang,Tsen-Fang Tsai |
| Dermatologica Sinica.2022;40(4)214 |
| [DOI] |
|
| 4 | Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata | |
| Yugang Gong,Li Luo,Ling Li,Xun He,Wei Lu,Xiaowei Sha,Yujie Mao |
| Experimental Dermatology.2021;30(2)278 |
| [DOI] |
|
| 5 | Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin | |
| Samia A Ibrahim,Abdulla M Esawy,Ahmed S Abdelshafy |
| Dermatologic Therapy.2019;32(5)278 |
| [DOI] |
|
| 6 | Development and validation of a liquid chromatographic method for the analysis of squaric acid dibutyl ester and its impurities | |
| Marwa F. Mansour,Peixi Zhu,Ann Van Schepdael,Erwin Adams |
| Journal of Pharmaceutical and Biomedical Analysis.2017;141(5)165 |
| [DOI] |
|
